Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Deciphering Rheumatoid Arthritis-associated Interstitial Lung Disease Pathogenesis 2

NCT04227535 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.

NCT NCT04227535
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04227535 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Deciphering Rheumatoid Arthritis-associated Interstitial Lung Disease Pathogenesis 2
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Phase
Observational
Overall status
Active, not recruiting
Start date
February 3, 2020
Completion date
October 1, 2027
Enrollment
509 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

interstitial lung disease, rheumatoid arthritis